Live Oak Acquisition in an 8-K filing announced that shareholders approved to proposed merger with Danimer Scientific.
Terms of the $525 million deal for the bioplastic company also calls for Danimer to trade on the NYSE. The transaction implies an equity valuation for Danimer of approximately $890 million at closing. Read more.
Live Oak Stockholders Approve $525M Danimer Scientific Merger
